From compliance procedures that far exceed industry standards to finding new ways to put quality at the forefront throughout the compounding process, we are committed to exceeding requirements and expectations in every patient prescription we deliver.
At the heart of this commitment are our two state-of-the-art pharmacies, our headquarters in Dallas, Texas, and a location in Ridgeland, Mississippi. Throughout these facilities, we take extra steps and make extra investments to go beyond industry requirements and produce medications of the highest quality and sterility.
patient-specific prescriptions provided per year
pump patients served per year
pharmacists dedicated to the preparation of TDD medications
third-party testing of all stock solutions*
*Third-party testing for pH, sterility, potency, endotoxins and particulate matter
day BUD at room temperature (average 34 days) for all formulary medications†, eliminating the stress of missed appointments
†All patient-specific dispenses within maximum concentrations (based on AIS Healthcare in-house data for 120,000 aseptically processed and terminally sterilized patient-specific prescriptions in 2019)
sterility assurance level for unprecedented quality and patient safety
All 503A specialty compounding pharmacies like ours must meet United States Pharmacopeia (USP) guidelines along with all state and local regulations. In many ways, we far exceed these requirements, doing more to put patient safety first.
|AIS Healthcare quality standard||USP <797> guidelines|
|All stock solutions are prepared by a licensed pharmacist and tested by an outside, independent lab for sterility, potency, particulate matter, pH and endotoxins before use in compounding||Not required|
|Compounding done only by licensed pharmacists||Compounder not required to be licensed pharmacist|
|Enhanced contamination-control procedures, including full-body sterile garb for cleanroom personnel||Only sterile gloves required for cleanroom personnel|
|Multiple 0.22-micron sterilizing-grade filtration steps, including filter integrity testing, to ensure medication sterility||Only one 0.22-micron sterilizing-grade filtration step required|
|Four independent cleanroom certifications per year||Only two required per year|
|Non-viable particle count done 12 times per year; combined viable air and surface sampling done no fewer than 50 times per year||Non-viable particle count and viable air sampling required twice per year; surface sampling required periodically|
With a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard that only AIS Healthcare uses—we are able to achieve unprecedented sterility assurance and extended beyond-use-date (BUD).